hemochromatosis – diagnosis and management

34
S L I D E 1 Hemochromatosis – Diagnosis and Management Pramod K. Mistry, MA, PhD, MD, FRCP Professor of Pediatrics and Medicine Chief, Pediatric Gastroenterology and Hepatology Indian Association for the Study of the Liver ‘Metabolic Liver Disease’ Mumbai. January 13, 2012

Upload: marsha

Post on 24-Feb-2016

44 views

Category:

Documents


0 download

DESCRIPTION

Hemochromatosis – Diagnosis and Management. Pramod K. Mistry , MA, PhD, MD, FRCP Professor of Pediatrics and Medicine Chief, Pediatric Gastroenterology and Hepatology Indian Association for the Study of the Liver ‘Metabolic Liver Disease’ Mumbai. January 13, 2012. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Hemochromatosis  – Diagnosis and Management

S L I D E 1

Hemochromatosis – Diagnosis and Management 

Pramod K. Mistry, MA, PhD, MD, FRCPProfessor of Pediatrics and MedicineChief, Pediatric Gastroenterology and Hepatology

Indian Association for the Study of the Liver‘Metabolic Liver Disease’Mumbai. January 13, 2012

Page 2: Hemochromatosis  – Diagnosis and Management

Non-contrast CT

65 yr old male, ferritin 2660, AFP 6324DDx GSD, thorotrast, amiodarone, cisplatin

What is the diagnosis?

Page 3: Hemochromatosis  – Diagnosis and Management

Inherited Causes of Cirrhosis

a1 – antitrypsindeficiency

Other

CFWilson's

Familial intrahepatic cholestasis

Hemochromatosis

Newborn and infants Adults

Inherited Causes of Cirrhosis

Page 4: Hemochromatosis  – Diagnosis and Management

PituitaryGonadotropin

deficiency

Skin bronzingCardiomyopathyConduction disordersCirrhosisHepatocellular carcinomaDiabetes mellitus

BacteremiaTesticular atrophy Arthropathy

ArthritisPseudogout

Hemochromatosis - Clinical ManifestationsClinical Manifestations

Page 5: Hemochromatosis  – Diagnosis and Management

Clinical Manifestations of Hereditary Hemochromatosis

Page 6: Hemochromatosis  – Diagnosis and Management

Serum TransferrinQuantitative

iron TIBC saturation Ferritinhepatic iron

(mg/dL) (mg/dL) (%) (mg/dL) (mg/g dry wt)

60-180 230-370 20-50 20-200 300-1500

>180 <300 >50 >300>3000

Hemochromatosis

Normal

Hemochromatosis - Iron Balance Values

Page 7: Hemochromatosis  – Diagnosis and Management
Page 8: Hemochromatosis  – Diagnosis and Management

Classification of Iron Overload Syndromes

Page 9: Hemochromatosis  – Diagnosis and Management

Ingested10-20 mg/day

Absorbed1-2 mg/day

LostGut, skin, urine - 1-2 mg/dayMenses - 30 mg/month

Normal Iron BalanceNormal Iron Balance

In HH daily absorption of iron is 2-4 mg despite systemic iron overload

Page 10: Hemochromatosis  – Diagnosis and Management

Pietrangelo, A. N Engl J Med 2004;350:2383-2397

Iron Homeostasis in Health and Disease

HH – sparing of Kuppfer cells

Page 11: Hemochromatosis  – Diagnosis and Management

Iron Transport and StorageTransport

Transferrin - two iron atoms

Intracellular storageFerritin - thousands of iron atoms

Total body iron - 4g

Storageiron

Other

RBCs

Iron Transport and Storage

Page 12: Hemochromatosis  – Diagnosis and Management

Normal Hfe Mutation ‘Mild’ Hemochromatosis

Page 13: Hemochromatosis  – Diagnosis and Management

TfR2 hemochromatosisMild iron overload

HJV hemochromatosisMassive iron overload

HAMP hemochromatosisDramatic iron overload

Ferroportin hemochromatosis –Tissue iron overload withRelative circulatory iron deficiency

Page 14: Hemochromatosis  – Diagnosis and Management

a Heavy chain

b2 microglobulin

a1 a2

a3

C282Y Mutation

H63D Mutation

NH2NH2

COOH

COOH

HFE Protein StructureHFE Protein Structure

Bacon BR, et al. Gastroenterology 1999; 116: 193

S65Cmutation

Page 15: Hemochromatosis  – Diagnosis and Management

What about India?

Page 16: Hemochromatosis  – Diagnosis and Management

Global Prevalence of HFE MutationsFrequency

(%)

C282Y H63D

Population allelic allelic

United Kingdom 6.412.8Norway 6.411.2Denmark 9.512.2Finland 011.8Former USSR 1.010.4Germany 3.914.8Italy 0.512.6Spain 3.226.3Greece 1.313.5Saudi Arabia 08.5Africa 02.6Indian subcontinent 0.28.4Asia 01.9Australasia 00.2Americas 0.72.6

Bacon, et al., Gastroenterology 1999; 116:193

Global Prevalence of HFE Mutations

Page 17: Hemochromatosis  – Diagnosis and Management

Andrews, N. C. et al. N Engl J Med 2005;353:189-198

Pietrangelo, A. N Engl J Med 2004;350:2383-2397

Page 18: Hemochromatosis  – Diagnosis and Management

Total body iron(g)

Age (years)

0

20

30

40

20 30 50

10

10 40

­ Serum

iron

Cirrhosis, organ failure

­ Hepatic

iron

Tissue injury

Normal

Natural HistoryHemochromatosis

Page 19: Hemochromatosis  – Diagnosis and Management

Phenotype Expression·Men > women

· Increases with age

·Correlates with amount of iron in the diet

·Chronic hemolysis, alcoholism, steatohepatitis, hepatitis C

Phenotype Expression

Page 20: Hemochromatosis  – Diagnosis and Management

Risk of HCC 119 x NCirrhosis 10 xNCardiomyopathy 306 x NDiabetes mellitus 10 x NReduced survival in cirrhotic HH. Non-cirrhotic HH, normal survival

(Niederau, Gastro 1996 250 patients followed for 14 +/- 7 yrs – 69 patients died)

Prognosis

Page 21: Hemochromatosis  – Diagnosis and Management

Serum Transferrin Quantitativeiron TIBC saturation Ferritin hepatic iron

(mg/dL) (mg/dL) (%) (mg/dL) (mg/g dry wt)

60-180 230-370 20-50 20-200 300-1500

>180 <300 >50 >300 >3000Hemochromatosis

Normal

Iron Balance Values

Page 22: Hemochromatosis  – Diagnosis and Management

Family history or suspicion of hemochromatosis

Repeat iron panel high; Ferritin >1000Elevated AST/ALTExtrahepatic manifestations of iron overload; Positive FH

Therapeutic Phlebotomy,response confirms diagnosis

% sat. >50%Ferritin

>250 mg/L >300 mg/L

­ stainable Fe Iron index >2

Fe / TIBC -% saturationFerritin

Liver biopsy with iron stain and quantitative iron

? Modified Diagnostic Algorithm for Use in IndiaDiagnostic Testing

Equivocal results

Page 23: Hemochromatosis  – Diagnosis and Management

Interpretation of Ferritin Levels

­ Ferritin and

Normal ferritin and ¯ iron

¯ Ferritin and ¯ iron

­ iron

¯ iron

Hemochromatosis

Acute liver injury

Acute phase reactant

Chronic disease

Iron deficiency

Interpretation of Ferritin Levels

Page 24: Hemochromatosis  – Diagnosis and Management

Index

Normals AlcoholicHeterozygotes

HemochromatosisHomozygotes

Precirrhotic

Cirrhotic

Liver iron Age

0

1

2

3

4

5

1015

(mmol/g) (yr)

Hepatic Iron Index

Hepatic Iron Index

Page 25: Hemochromatosis  – Diagnosis and Management

PhlebotomyAcute

1 unit (250 mg Fe) weekly or biweekly until mildly anemic

Maintenance Once iron stores are depleted (ferritin <50ng/ml, transferrin sat <50%)

continue with phlebotomy every 2-3 months. Monitor hemoglobin, ferritin and transferrin saturation

Phlebotomy – Therapy for Iron Overload

Page 26: Hemochromatosis  – Diagnosis and Management

Phlebotomy Improves Survival

Preventable: all clinical manifestations

Reversible: cardiac dysfunction, glucose intolerance, hepatomegaly,

skin pigmentation

Irreversible: cirrhosis risk of hepatocellular carcinomaarthropathy, hypogonadism

Phlebotomy Improves Survival

Niederau C, et al. N Engl J Med 1985; 313:1256

Page 27: Hemochromatosis  – Diagnosis and Management

Iron Depletion Improves Survival

0

40

80

100

20

10 15 255 20

60

0

Cumulative survival

(%)

Time (years)

Iron depleted after 18 months

Untreated after 18 months

Iron Depletion Improves Survival

Niederau C, et al. N Engl J Med 1985; 313:1256

Page 28: Hemochromatosis  – Diagnosis and Management

Response to Phlebotomy

0

40

60

80

100

4 12 20 24 32

500

1000

1500

20

80 16 28

2000

Transferrin%

Time (months)

Hgbdrop

s

Ferritinng/ml

Phlebotomy

Serum ferritin

Transferrin saturation

Response to Phlebotomy

Edwards CQ, et al. Hospital Practice 1991; 26:30

Page 29: Hemochromatosis  – Diagnosis and Management

Quantitative Phlebotomy As A Diagnostic Test For HH

• Indication

liver biopsy cannot be performed but suspected iron overload• Determine the number of weekly 500 mL phlebotomies,

each of which removes 200 to 250 mg of elemental iron,

which are required to produce iron deficient erythropoiesis. • Normal men have approximately 1 g of iron stores. • Therefore, 4-5 phlebotomies during 4-8 weeks will produce

an iron deficiency anemia• In contrast, patients with significant iron loading usually

have at least 5 g (and often 20 g or more) of iron stores, requiring at least

20 units of phlebotomy to induce iron deficiency

Page 30: Hemochromatosis  – Diagnosis and Management

Inherited Causes of Cirrhosis

a1 – antitrypsindeficiency

Other

CFWilson's

Familial intrahepatic cholestasis

Hemochromatosis

Newborn and infants Adults

Genetic Diseases - LiverInherited Causes of Cirrhosis

Page 31: Hemochromatosis  – Diagnosis and Management

Neonatal Hemochromatosis

• Late fetal or early neonatal loss• Renal hypoplasia• Often with oligohydramniosFeatures• Raised ferritin• Hepatocellular synthetic failure• Extensive cholestasis• Low or absent AST/ALT• AFP >200,000• Systemic iron overload – Dx investigation: buccal

biopsy

Page 32: Hemochromatosis  – Diagnosis and Management

Andrews, N. C. et al. N Engl J Med 2005;353:189-198

Neonatal Hemochromatosis

Page 33: Hemochromatosis  – Diagnosis and Management

NH – pathogenetic mechanisms

• Non-specific consequence of any type of liver injury• Genetic: Recurrence rate 80% in children born to same

mothers*

• Infectious disease• Immune mediated disease

• Occurs in hemolysis with giant cell hepatitiscongental nephrotic syndrome, arthrogryphosis multiplex, all allo-immune mediated maternal diseases

• IgG from NH affected mother into pregnant mouse dams leads to liver failure in the newborn

Page 34: Hemochromatosis  – Diagnosis and Management

NH – Treatments

• IVIG (Whitington, Lancet, 2001)• Chelation/antioxidant cocktail• NAC• Transplant